UBS Group’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,763
| Closed | -$8.22K | – | 9264 |
|
2025
Q1 | $8.22K | Buy |
4,763
+4,243
| +816% | +$7.32K | ﹤0.01% | 7456 |
|
2024
Q4 | $5.12K | Sell |
520
-1,249
| -71% | -$12.3K | ﹤0.01% | 7455 |
|
2024
Q3 | $15.8K | Buy |
+1,769
| New | +$15.8K | ﹤0.01% | 6291 |
|
2023
Q1 | – | Sell |
-44
| Closed | -$2.56K | – | 8906 |
|
2022
Q4 | $2.56K | Buy |
+44
| New | +$2.56K | ﹤0.01% | 8459 |
|
2022
Q2 | – | Sell |
-19
| Closed | -$8K | – | 9615 |
|
2022
Q1 | $8K | Buy |
19
+11
| +138% | +$4.63K | ﹤0.01% | 7639 |
|
2021
Q4 | $7K | Sell |
8
-6
| -43% | -$5.25K | ﹤0.01% | 8038 |
|
2021
Q3 | $7K | Buy |
14
+10
| +250% | +$5K | ﹤0.01% | 7173 |
|
2021
Q2 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 7724 |
|
2021
Q1 | – | Sell |
-11
| Closed | -$13K | – | 8158 |
|
2020
Q4 | $13K | Buy |
+11
| New | +$13K | ﹤0.01% | 6264 |
|